Science & Technology Partners, L.P.

CIK 0002029433 · GREENWICH, CT · Quarter end: 2026-06-30 · Filed on: 2026-08-14 · Open the SEC source

Science & Technology Partners, L.P. reported 84 positions worth $593.3M as of June 30, 2026 (13F filed August 14, 2026). Largest holding: NVDA (5.6%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$593.3M
2026 Q2
Positions
84
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
48.1%
Est. Net Flow (Q)
2026 Q2
10 / 84 positions shown
#SymbolCompanyTypeValue% Port.Shares1YYTD
1NVDANVIDIA ORDSH$33.0M5.56%164,870
2GHGUARDANT HEALTH INCSH$31.3M5.28%208,817
3AAPLAPPLE ORDSH$30.4M5.12%104,985
4NTRANATERA INCSH$29.8M5.03%109,880
5COHRCOHERENT CORPSH$29.5M4.97%74,725
6LRCXLAM RESEARCH CORPSH$28.1M4.74%64,913
7PLPLANET LABS PBCSH$27.3M4.61%824,733
8FPSFORGENT POWER SOLUTIONS INCSH$26.1M4.41%468,000
9BEBLOOM ENERGY CORPSH$25.8M4.35%85,210
10AEHRAEHR TEST SYSSH$23.9M4.03%249,000

The free plan shows the top 10 positions. The remaining 74 positions, the full portfolio and quarter changes unlock with Pro.

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does Science & Technology Partners, L.P. hold as of Q2 2026?

Science & Technology Partners, L.P. reported 84 positions worth $593.3M in its Q2 2026 13F filing. Largest positions: NVDA (5.6%), GH (5.3%), AAPL (5.1%), NTRA (5.0%) and COHR (5.0%).

What did Science & Technology Partners, L.P. buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did Science & Technology Partners, L.P. sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.